002166.SZ
莱茵生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 6.60
−2.08%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 2.0B | 1.8B | 1.5B | 1.4B |
| Cost of Revenue | 1.5B | 1.5B | 1.3B | 1.1B | 969.3M |
| Gross Profit | 534.5M | 526.3M | 519.6M | 364.7M | 431.4M |
| Operating Expenses | |||||
| R&D Expense | 53.5M | 58.4M | 57.5M | 48.4M | 44.3M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 150.0M | 149.0M | 141.0M | 139.7M | 104.4M |
| Selling & Marketing Expense | 79.4M | 75.8M | 63.5M | 54.0M | 44.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 346.4M | 341.4M | 303.5M | 277.0M | 207.3M |
| Cost and Expenses | 1.9B | 1.9B | 1.6B | 1.4B | 1.2B |
| Operating Income (EBIT) | 217.2M | 205.0M | 213.4M | 118.3M | 253.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 212.9M | 200.7M | 207.8M | 116.4M | 238.3M |
| Income Tax Expense | 50.0M | 47.8M | 40.7M | 18.0M | 50.0M |
| Bottom Line | |||||
| Net Income | 154.8M | 143.1M | 163.0M | 82.5M | 178.7M |
| Earnings from Cont. Ops | 162.9M | 152.9M | 167.2M | 98.3M | 188.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 154.8M | 143.1M | 163.0M | 82.5M | 178.7M |
| Per Share | |||||
| Basic EPS | CN¥0.21 | CN¥0.19 | CN¥0.22 | CN¥0.11 | CN¥0.29 |
| Diluted EPS | CN¥0.21 | CN¥0.19 | CN¥0.22 | CN¥0.11 | CN¥0.29 |
| Revenue Per Share | CN¥2.76 | CN¥2.78 | CN¥2.43 | CN¥1.99 | CN¥2.27 |
| Shares | |||||
| Basic Shares Outstanding | 742.0M | 735.9M | 728.7M | 750.1M | 616.3M |
| Diluted Shares Outstanding | 742.0M | 735.9M | 728.7M | 750.1M | 616.3M |
| Profitability Metrics | |||||
| EBITDA | — | 333.8M | 316.5M | 206.2M | 327.4M |
| D&A | — | 128.9M | 103.0M | 87.9M | 73.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026